By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

T-cell therapy represents a groundbreaking advancement in the field of immuno-oncology. This innovative treatment involves ...

The School of Medicine is a major international centre for teaching and research, and committed to the pursuit of improved human health. We combine progressive healthcare education and patient care ...

While her extensive car collection includes a lot of the usual suspects, there are also some absolute bangers in there, like a restomod '67 Ford Bronco, a murdered-out third-generation El Camino ...

The changes will extend the company's cash runway, enabling it to advance a tri-specific CAR T-cell candidate and its allogeneic cell therapy platform.

He holds an M.D. from the University of Oklahoma's College of Medicine. "I am incredibly excited to join Umoja as Chief Medical Officer at such an important time for both the company and the in vivo ...

CAR T-cell therapies have established themselves as a frequently very successful and overall promising treatment option for various blood cancers for which no other effective therapies are available.

Penn Medicine is advancing cancer treatment with its work in CAR T-cell therapy, an innovative immunotherapy that is reshaping the fight against blood cancers and rare genetic diseases. Penn Medicine ...

Carol M. Kopp edits features on a wide range of subjects for Investopedia, including investing, personal finance, retirement planning, taxes, business management, and career development.